Trexquant Investment LP Cullinan Oncology, Inc. Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$7.89 - $10.23 $275,794 - $357,589
34,955 New
34,955 $356,000
Q4 2022

Feb 13, 2023
SELL
$9.72 - $13.62 $130,325 - $182,616
-13,408 Reduced 56.68%
10,249 $108,000
Q3 2022

Nov 14, 2022
SELL
$11.82 - $15.42 $96,853 - $126,351
-8,194 Reduced 25.73%
23,657 $303,000
Q2 2022

Aug 11, 2022
BUY
$7.31 - $13.55 $232,830 - $431,581
31,851 New
31,851 $408,000

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email